BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16038370)

  • 41. Nafarelin versus danazol versus surgery.
    Redwine DB
    Fertil Steril; 1992 Aug; 58(2):455-6. PubMed ID: 1386034
    [No Abstract]   [Full Text] [Related]  

  • 42. Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study.
    Audebert A; Descamps P; Marret H; Ory-Lavollee L; Bailleul F; Hamamah S
    Eur J Obstet Gynecol Reprod Biol; 1998 Aug; 79(2):145-8. PubMed ID: 9720832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nafarelin: a new medical therapy for endometriosis.
    Henzl MR; Monroe SE
    Prog Clin Biol Res; 1990; 323():343-55. PubMed ID: 2137620
    [No Abstract]   [Full Text] [Related]  

  • 44. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
    Dlugi AM; Rufo S; D'Amico JF; Seibel MM
    Fertil Steril; 1988 May; 49(5):913-6. PubMed ID: 3129319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of endometriosis with the GnRH agonist nafarelin acetate.
    Jacobs LA; Field CS; Thie JL; Coulam CB
    Int J Fertil; 1991; 36(1):30-5. PubMed ID: 1672673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Results of treating endometriosis with nafarelin].
    Marianowski L; KamiƄski P
    Wiad Lek; 1994 Aug; 47(15-16):595-7. PubMed ID: 7716957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effectiveness of therapy of endometriosis with danazol and chlormadinone acetate and their effect on paraclinical parameters].
    Lembke J; Lembke S
    Zentralbl Gynakol; 1986; 108(6):341-6. PubMed ID: 2424194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gonadotropin-releasing hormone analogs in the treatment of endometriomas.
    Schenken RS
    Am J Obstet Gynecol; 1990 Feb; 162(2):579-81. PubMed ID: 2137974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose danazol after combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate and severe endometriosis.
    Morgante G; Ditto A; La Marca A; De Leo V
    Hum Reprod; 1999 Sep; 14(9):2371-4. PubMed ID: 10469713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis.
    Finkelstein JS; Arnold AL
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1214-9. PubMed ID: 10199756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nafarelin in the treatment of infertility caused by endometriosis.
    Barlow DH
    Am J Obstet Gynecol; 1990 Feb; 162(2):576-9. PubMed ID: 2137973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T; Sakata M; Terakawa N
    Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group.
    Wheeler JM; Knittle JD; Miller JD
    Am J Obstet Gynecol; 1993 Jul; 169(1):26-33. PubMed ID: 8333471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures.
    Zhao SZ; Kellerman LA; Francisco CA; Wong JM
    J Reprod Med; 1999 Dec; 44(12):1000-6. PubMed ID: 10649809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Moncayo R; Wilken J; Wilde N; Kann D; Leidenberger F
    Obstet Gynecol; 1991 Jan; 77(1):169-70. PubMed ID: 1824574
    [No Abstract]   [Full Text] [Related]  

  • 58. The efficacy of drugs in the management of endometriosis.
    Bulletti C; Flamigni C; Polli V; Giacomucci E; Albonetti A; Negrini V; Galassi A; Morselli-Labate AM
    J Am Assoc Gynecol Laparosc; 1996 Aug; 3(4):495-501. PubMed ID: 9050678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nafarelin for endometriosis.
    Sharts-Engel NC
    MCN Am J Matern Child Nurs; 1992; 17(4):224. PubMed ID: 1386133
    [No Abstract]   [Full Text] [Related]  

  • 60. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results.
    Wheeler JM; Knittle JD; Miller JD
    Am J Obstet Gynecol; 1992 Nov; 167(5):1367-71. PubMed ID: 1442992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.